Nuo Therapeutics, Inc.·5

Apr 26, 9:24 PM ET

SHEEDY CHARLES E 5

5 · Nuo Therapeutics, Inc. · Filed Apr 26, 2022

Insider Transaction Report

Form 5
Period: 2020-12-31
Transactions
  • Purchase

    Common Stock

    2020-10-05$0.40/sh+175,000$70,0008,763,517 total
  • Other

    Warrants to purchase Common Stock

    2020-10-05+1,431,6151,431,615 total
    Exercise: $0.40From: 2020-10-05Exp: 2025-10-05Common Stock (1,431,615 underlying)
  • Other

    Common Stock

    2020-10-05$0.40/sh+302,205$120,8828,588,517 total
  • Other

    Warrants to purchase Common Stock

    2020-10-05165,0000 total
    Exercise: $0.40Common Stock (165,000 underlying)
Holdings
  • Common Stock

    (indirect: By Trust)
    3,365
Footnotes (7)
  • [F1]Conversion shares acquired in accordance with Recapitalization Agreement Schedule dated as of October 5, 2020
  • [F2]Purchase shares acquired in accordance with Recapitalization Agreement Schedule dated as of October 5, 2020
  • [F3]The Reporting Person disclaims beneficial ownership over such shares except to the extent of his pecuniary interest therein.
  • [F4]Acquired in accordance with Recapitalization Agreement Schedule dated as of October 5, 2020
  • [F5]The reported transactions involved a recapitalization resulting in the deemed cancellation of the "old" warrants and the deemed grant of "replacement" warrants.
  • [F6]Cancelled in accordance with Recapitalization Agreement Schedule dated as of October 5, 2020
  • [F7]Originally exercisable on 11/15/19 and 12/06/19, with expirations of 11/15/24 and 12/06/24, respectively, for 15,000 shares and 150,000 shares

Documents

1 file
  • 5
    rdgdoc.xmlPrimary

    FORM 5